Immunology Co-Op

Company Summary:

FL87, Inc. is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.

FL87 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Syros Pharmaceuticals (SYRS), Seres Therapeutics (NASDAQ:MCRB), Generate Biomedicines, Tessera Tx, Evelo Biosciences (EVLO), and Indigo Agriculture.

Are you ready to be part of a pioneering biotech company on the frontline of developing a novel approach to gene therapy that can address currently untreatable diseases? 

As a member of our therapeutic discovery team, you'll explore the forefront of scientific discovery—from developing and executing in vitro assays on primary human T cells to analysing therapeutic candidates in humanized mouse models. 

We're Looking For:

• Highly motivated and enthusiastic co-op students eager to dive into groundbreaking research.
• Ability to learn new techniques and to think creatively about problem solving
• Individuals with a background in cell biology, ideally T cell biology,  with a desire to master novel techniques. Experience with immunology and nucleic acid modality is a plus.

What You'll Do:

• Contribute to primary immune cell isolation from leukopak and inventory management.
• Culture mammalian cells and perform gene delivery via transfection
• Execute in vitro assays to evaluate immune cell function, including multi-color flow cytometry, cytotoxicity assays and other functional readouts under the guidance of manager and other scientists on the team.
• Conduct ex vivo analysis of immune cells through tissue processing and downstream assays and analyses 

Why Join Us?

• Be part of an inspiring mission to develop therapeutic solutions for autoimmune and cancer patients.
• Collaborate with a dynamic team of experimental scientists.
• Develop a diverse skill set and gain unparalleled experience in cutting-edge research.

Qualifications:

• Pursuing a BS or MS in Molecular Biology, Cell Biology, Bioengineering, Immunology, or a related field
• Experience with cell culture and aseptic technique
• Detail oriented, self-motivated, and comfortable working with highly technical projects and personnel
• Strong communication and interpersonal skills
• Competence with Excel and PowerPoint
• Experience working with immune cells and a general understanding of immunology is highly preferred
• Experience with flow cytometry and/or ex vivo mouse model sample processing is preferred

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team!  See all our open opportunities across Flagship Pioneering’s Ecosystem!

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including:  Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO),  Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated.  Learn more about our Company Creation Model.

Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

 

The salary range for this role is $20 - $40. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. FL87 currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on FL87’s good faith estimate as of the date of publication and may be modified in the future.